[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes in Heart Failure with Preserved vs. Reduced Ejection Fraction in Patients with Iron Deficiency Anemia (with propensity score matching)",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes in Heart Failure with Preserved vs. Reduced Ejection Fraction in Patients with Iron Deficiency Anemia (with propensity score matching)",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Outcomes in Heart Failure with Preserved vs. Reduced Ejection Fraction in Patients with Iron Deficiency Anemia (with propensity score matching)",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 4,756,7151\nHeart failure with reduced ejection fraction\nN = 4,756,7151\np-value2\n\n\n\n\nAge, y\n72 (13)\n72 (13)\n&lt;0.001\n\n\nSex\n\n\n\n\n&lt;0.001\n\n\n    Female\n2,442,390 (51%)\n2,171,440 (46%)\n\n\n\n\n    Male\n2,314,325 (49%)\n2,585,275 (54%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n3,344,800 (70%)\n3,319,335 (70%)\n\n\n\n\n    Asian or Pacific Islander\n101,455 (2.1%)\n102,460 (2.2%)\n\n\n\n\n    Black\n819,515 (17%)\n840,980 (18%)\n\n\n\n\n    Hispanic\n360,440 (7.6%)\n361,855 (7.6%)\n\n\n\n\n    Native American\n25,280 (0.5%)\n26,435 (0.6%)\n\n\n\n\n    Other\n105,225 (2.2%)\n105,650 (2.2%)\n\n\n\n\nElixhauser comorbidity index\n6.68 (2.01)\n6.59 (2.07)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n0.001\n\n\n    $1 - $51,999\n1,496,525 (31%)\n1,515,615 (32%)\n\n\n\n\n    $52,000 - $65,999\n1,286,830 (27%)\n1,286,290 (27%)\n\n\n\n\n    $66,000 - $87,999\n1,118,680 (24%)\n1,106,925 (23%)\n\n\n\n\n    $88,000 or more\n854,680 (18%)\n847,885 (18%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n613,260 (13%)\n658,035 (14%)\n\n\n\n\n    Medicaid\n402,115 (8.5%)\n429,145 (9.0%)\n\n\n\n\n    Medicare\n3,654,795 (77%)\n3,574,360 (75%)\n\n\n\n\n    Other\n86,545 (1.8%)\n95,175 (2.0%)\n\n\n\n\nHospital region\n\n\n\n\n&gt;0.9\n\n\n    Midwest\n1,156,755 (24%)\n1,156,755 (24%)\n\n\n\n\n    Northeast\n890,230 (19%)\n890,230 (19%)\n\n\n\n\n    South\n1,897,245 (40%)\n1,897,245 (40%)\n\n\n\n\n    West\n812,485 (17%)\n812,485 (17%)\n\n\n\n\nHypertension\n402,335 (8.5%)\n377,765 (7.9%)\n&lt;0.001\n\n\nHyperlipidemia\n2,649,390 (56%)\n2,638,400 (55%)\n0.011\n\n\nPeripheral vascular disease\n668,450 (14%)\n688,295 (14%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n1,998,760 (42%)\n1,873,735 (39%)\n&lt;0.001\n\n\nCoronary artery disease\n2,201,465 (46%)\n2,392,615 (50%)\n&lt;0.001\n\n\nDementia\n492,145 (10%)\n468,275 (9.8%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n2,141,595 (45%)\n2,129,180 (45%)\n0.002\n\n\nValvular heart disease\n609,675 (13%)\n618,055 (13%)\n0.005\n\n\nAtrial fibrillation\n1,732,860 (36%)\n1,799,210 (38%)\n&lt;0.001\n\n\nObesity\n1,260,700 (27%)\n1,115,595 (23%)\n&lt;0.001\n\n\nPresence of pacemaker\n517,560 (11%)\n534,450 (11%)\n&lt;0.001\n\n\nprevious MI\n562,475 (12%)\n807,630 (17%)\n&lt;0.001\n\n\nPior cardiac surgery\n675,155 (14%)\n730,805 (15%)\n&lt;0.001\n\n\nMalnutrition\n408,180 (8.6%)\n424,460 (8.9%)\n&lt;0.001\n\n\nCancer\n236,205 (5.0%)\n236,690 (5.0%)\n0.8\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Outcomes in Heart Failure with Preserved vs. Reduced Ejection Fraction in Patients with Iron Deficiency Anemia (with propensity score matching)",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 4,756,7151\nHeart failure with reduced ejection fraction\nN = 4,756,7151\np-value2\n\n\n\n\nDied during hospitalization\n199,540 (4.2%)\n278,470 (5.9%)\n&lt;0.001\n\n\nLength of stay (days)\n6.4 (7.3)\n6.7 (7.8)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n78,960 (123,104)\n89,454 (157,003)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test\n\n\n\n\n\n\n\n\n\nMultivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n1.44\n1.42, 1.46\n&lt;0.001\n\n\nAge, y\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.15\n1.13, 1.16\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.10\n1.06, 1.16\n&lt;0.001\n\n\n    Black\n0.87\n0.85, 0.89\n&lt;0.001\n\n\n    Hispanic\n0.96\n0.93, 0.99\n0.010\n\n\n    Native American\n1.21\n1.11, 1.32\n&lt;0.001\n\n\n    Other\n1.06\n1.01, 1.11\n0.018\n\n\nElixhauser comorbidity index\n1.19\n1.19, 1.20\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.96\n0.94, 0.98\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.93\n0.91, 0.95\n&lt;0.001\n\n\n    $88,000 or more\n0.93\n0.91, 0.96\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.76\n0.73, 0.78\n&lt;0.001\n\n\n    Medicare\n0.79\n0.76, 0.81\n&lt;0.001\n\n\n    Other\n1.59\n1.48, 1.70\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.23\n1.19, 1.27\n&lt;0.001\n\n\n    South\n1.01\n0.98, 1.04\n0.4\n\n\n    West\n1.05\n1.01, 1.08\n0.004\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.59, 0.63\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.60, 0.62\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.93, 0.97\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.87, 0.90\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.79, 0.81\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.74, 0.77\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.03, 1.07\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.22\n1.19, 1.25\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.18\n2.14, 2.23\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.96, 0.99\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.59, 0.62\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.63, 0.67\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.82, 0.86\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.54\n1.50, 1.57\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.80, 0.83\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\n\nMultivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n0.28\n0.25, 0.30\n&lt;0.001\n\n\nAge, y\n-0.03\n-0.03, -0.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.30\n0.28, 0.33\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.35\n0.21, 0.48\n&lt;0.001\n\n\n    Black\n0.03\n-0.02, 0.08\n0.3\n\n\n    Hispanic\n0.07\n0.00, 0.15\n0.064\n\n\n    Native American\n-0.02\n-0.23, 0.19\n0.9\n\n\n    Other\n0.48\n0.36, 0.61\n&lt;0.001\n\n\nElixhauser comorbidity index\n0.46\n0.45, 0.48\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.02\n-0.06, 0.02\n0.4\n\n\n    $66,000 - $87,999\n0.05\n0.00, 0.10\n0.042\n\n\n    $88,000 or more\n0.11\n0.04, 0.18\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.13\n0.05, 0.20\n&lt;0.001\n\n\n    Medicare\n-0.06\n-0.11, -0.01\n0.014\n\n\n    Other\n-0.07\n-0.19, 0.04\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.0\n0.93, 1.1\n&lt;0.001\n\n\n    South\n0.36\n0.28, 0.45\n&lt;0.001\n\n\n    West\n-0.20\n-0.30, -0.10\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.52\n-0.57, -0.48\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.86\n-0.90, -0.83\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.03\n-0.07, 0.01\n0.094\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.12\n-0.15, -0.10\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.62\n-0.65, -0.59\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.47\n-0.50, -0.43\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.23\n0.18, 0.27\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.01\n-0.04, 0.07\n0.6\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.8\n1.8, 1.9\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.06\n-0.09, -0.04\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.21\n-0.25, -0.17\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.99\n-1.0, -0.96\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.60\n-0.62, -0.57\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4.1\n4.0, 4.2\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.65\n-0.68, -0.62\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n9,784\n9,046, 10,523\n&lt;0.001\n\n\nAge, y\n-943\n-1,000, -887\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n7,782\n7,302, 8,261\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n16,010\n11,765, 20,256\n&lt;0.001\n\n\n    Black\n-3,288\n-4,709, -1,867\n&lt;0.001\n\n\n    Hispanic\n17,755\n15,022, 20,488\n&lt;0.001\n\n\n    Native American\n-14,116\n-18,270, -9,963\n&lt;0.001\n\n\n    Other\n25,228\n20,550, 29,906\n&lt;0.001\n\n\nElixhauser comorbidity index\n5,833\n5,330, 6,336\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1,270\n113, 2,427\n0.031\n\n\n    $66,000 - $87,999\n4,346\n2,962, 5,730\n&lt;0.001\n\n\n    $88,000 or more\n12,385\n9,951, 14,820\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-11,979\n-13,939, -10,019\n&lt;0.001\n\n\n    Medicare\n-4,360\n-5,540, -3,180\n&lt;0.001\n\n\n    Other\n-2,442\n-4,967, 83\n0.058\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n24,137\n20,185, 28,089\n&lt;0.001\n\n\n    South\n14,347\n12,115, 16,579\n&lt;0.001\n\n\n    West\n41,695\n36,381, 47,009\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,327\n-7,481, -5,174\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,967\n-8,755, -7,179\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,146\n4,200, 6,092\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n9,071\n8,416, 9,725\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-13,015\n-13,970, -12,059\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n17,595\n16,238, 18,952\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,866\n-13,733, -11,999\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,513\n-3,676, -1,350\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n24,068\n23,152, 24,984\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-445\n-1,051, 161\n0.15\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,237\n-6,235, -4,239\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-18,098\n-18,821, -17,376\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-13,488\n-14,124, -12,852\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n56,685\n53,215, 60,156\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-15,059\n-15,753, -14,364\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]